Sysmex Corp
TSE:6869

Watchlist Manager
Sysmex Corp Logo
Sysmex Corp
TSE:6869
Watchlist
Price: 3 177 JPY 1.44% Market Closed
Market Cap: 2T JPY
Have any thoughts about
Sysmex Corp?
Write Note

Sysmex Corp
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sysmex Corp
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sysmex Corp
TSE:6869
Cash from Financing Activities
-ÂĄ6.7B
CAGR 3-Years
31%
CAGR 5-Years
17%
CAGR 10-Years
-3%
Terumo Corp
TSE:4543
Cash from Financing Activities
-ÂĄ97.5B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-16%
Olympus Corp
TSE:7733
Cash from Financing Activities
-ÂĄ327.6B
CAGR 3-Years
-44%
CAGR 5-Years
-31%
CAGR 10-Years
-23%
Nihon Kohden Corp
TSE:6849
Cash from Financing Activities
-ÂĄ6.1B
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
-5%
JEOL Ltd
TSE:6951
Cash from Financing Activities
-ÂĄ3.7B
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
-13%
Fukuda Denshi Co Ltd
TSE:6960
Cash from Financing Activities
-ÂĄ17.1B
CAGR 3-Years
-78%
CAGR 5-Years
-42%
CAGR 10-Years
-8%
No Stocks Found

Sysmex Corp
Glance View

Market Cap
2T JPY
Industry
Health Care

Sysmex Corporation, a global leader in healthcare and diagnostics, specializes in innovative laboratory solutions and instruments that enhance patient care and streamline clinical workflows. Established in 1968 and headquartered in Kobe, Japan, Sysmex has evolved from a domestic player to an international powerhouse, with a presence in over 190 countries. With a steadfast commitment to research and development, the company focuses on hematology, immunochemistry, and molecular diagnostics, continually pushing the boundaries of technology. Their flagship products, which include advanced analyzers and systems, empower healthcare professionals to make timely and accurate clinical decisions, ultimately improving patient outcomes across the globe. For investors, Sysmex embodies a compelling growth story in the ever-expanding healthcare market. The aging population and increasing prevalence of chronic diseases drive demand for diagnostic solutions, positioning Sysmex to capitalize on these trends. The company’s robust financial performance is evidenced by consistent revenue growth and a strong balance sheet, supported by strategic collaborations and a diverse product portfolio. With a commitment to sustainability and social responsibility, Sysmex not only prioritizes profitability but also aims to contribute positively to global health challenges. As the world increasingly relies on advanced diagnostics, Sysmex stands out as a forward-thinking investment opportunity that combines financial stability with a meaningful social impact.

Intrinsic Value
2 973.08 JPY
Overvaluation 6%
Intrinsic Value
Price

See Also

What is Sysmex Corp's Cash from Financing Activities?
Cash from Financing Activities
-6.7B JPY

Based on the financial report for Sep 30, 2024, Sysmex Corp's Cash from Financing Activities amounts to -6.7B JPY.

What is Sysmex Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-3%

Over the last year, the Cash from Financing Activities growth was 73%. The average annual Cash from Financing Activities growth rates for Sysmex Corp have been 31% over the past three years , 17% over the past five years , and -3% over the past ten years .

Back to Top